Mitochondrial Disease-associated ImmunoDeficiencies
ConditionMitochondrial Disorders
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6+
SponsorUniversity Hospital, Bordeaux
About this trial
The study aims at characterizing the immune dysfunctions in patients with mitochondrial diseases. This has prognostic and diagnostic interest as well as potential for the discovery of new therapeutic strategies to alleviate disease burden.
Eligibility criteria
Qualifiers
Patient weighing more than 30kg
Person affiliated with or receiving a social security plan;
Patient with molecularly proven primary mitochondrial disease
Free, informed, written consent signed by parental authority holders for minor patients and the investigator prior to any examination required by the research and oral and/or written assent by the participant (depending on age).
Disqualifiers
Pregnant or breastfeeding women
Refusal to consent to participate in research,
Patients for whom molecular causes have not been formally identified (genetic analyses not performed, or no variant or variant of unknown significance after analysis).
Trial design
Treatments tested in this trial
- Patient cohort
- Control cohort
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov